07:00 , Sep 8, 2008 |  BioCentury  |  Finance

Ebb & Flow

Two of the biggest holders of Amylin stock reduced their positions on Aug. 27, according to SEC filings last Friday. The 27th was the day after Amylin disclosed four additional deaths among diabetes patients who...
07:00 , Jun 18, 2007 |  BioCentury  |  Finance

Ebb & Flow

Two recently created European venture capital firms last week announced interim closes of their first funds. Aescap Venture announced a second close of E43 million ($57.8 million), bringing to E102 million ($136.4 million) the total raised...
01:10 , Jun 13, 2007 |  BC Extra  |  Financial News

Athersys reverse merges, raises $65M

Athersys (Cleveland, Ohio) reverse merged with shell company BTHC VI (BVIC) and raised $65 million in a private placement of 13 million shares at $5. Cowen and National Securities were co-placement agents. Lead investor Radius...